Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020223403 - ANTICANCER SMAC DERIVATIVES

Publication Number WO/2020/223403
Publication Date 05.11.2020
International Application No. PCT/US2020/030548
International Filing Date 29.04.2020
IPC
C07D 207/06 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
207Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
02with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
04having no double bonds between ring members or between ring members and non-ring members
06with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
C07K 5/06 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
5Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04containing only normal peptide links
06Dipeptides
Applicants
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US]/[US]
Inventors
  • MICEWICZ, Ewa D.
  • RUCHALA, Piotr P.
Agents
  • SHISHIMA, Gina N.
Priority Data
62/840,23129.04.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTICANCER SMAC DERIVATIVES
(FR) DÉRIVÉS DE SMAC ANTICANCÉREUX
Abstract
(EN)
Embodiments provide for compositions and methods concerning lipid modification of Smacs for use in treating cancer.
(FR)
Selon des modes de réalisation, l'invention concerne des compositions et des procédés se rapportant à la modification lipidique de Smac en vue d'une utilisation dans le traitement du cancer.
Latest bibliographic data on file with the International Bureau